{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-269451","form_type":"8-K","ticker":"CERS","cik":"0001020214","company_name":"CERUS CORP","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.557200+00:00","generated_at":"2026-05-16T23:19:12.847293+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cerus Q3 revenue up 19% to $60.2M, raises FY2025 product revenue guidance","bullets":["Product revenue $52.7M (+15% YoY); total revenue $60.2M (+19% YoY).","GAAP net loss narrowed to $0.02M (near breakeven); non-GAAP adjusted EBITDA $5.0M.","U.S. IFC sales $3.9M, volumes up ~110% YoY; hospital demand increasing.","Full-year 2025 product revenue guidance raised to $202-204M (prev. $200-203M).","Cash and investments $78.5M; generated $1.9M operating cash flow in Q3."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-269451","json":"https://secwatch.observer/filing/0001193125-25-269451.json","markdown":"https://secwatch.observer/filing/0001193125-25-269451.md","text":"https://secwatch.observer/filing/0001193125-25-269451.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1020214/000119312525269451/0001193125-25-269451-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1020214/000119312525269451/cers-20251106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:19:12.847293+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}